Site navigation

Navigation

Sepsis (severe) - drotrecogin

Drotrecogin alpha (activated) for severe sepsis

Summary

Drotrecogin alfa (activated) is recommended for adult patients who have severe sepsis that has resulted in multiple organ failure (two or more major organs are not working properly) and are being given the most appropriate intensive care support for their condition. The use of drotrecogin al ...

Read the complete summary


Guidance documents

Implementing this guidance

  • None available

Other information

About this guidance

Technology appraisals TA84

Issued: September 2004

How this guidance was produced

See also:

See this guidance in practice:

Order printed copies of this guidance